JP2008532477A5 - - Google Patents

Download PDF

Info

Publication number
JP2008532477A5
JP2008532477A5 JP2007535933A JP2007535933A JP2008532477A5 JP 2008532477 A5 JP2008532477 A5 JP 2008532477A5 JP 2007535933 A JP2007535933 A JP 2007535933A JP 2007535933 A JP2007535933 A JP 2007535933A JP 2008532477 A5 JP2008532477 A5 JP 2008532477A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
group
nos
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007535933A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008532477A (ja
JP5109131B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2006/302684 external-priority patent/WO2006085684A2/en
Publication of JP2008532477A publication Critical patent/JP2008532477A/ja
Publication of JP2008532477A5 publication Critical patent/JP2008532477A5/ja
Application granted granted Critical
Publication of JP5109131B2 publication Critical patent/JP5109131B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007535933A 2005-02-10 2006-02-09 膀胱癌を診断する方法 Expired - Fee Related JP5109131B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US65231805P 2005-02-10 2005-02-10
US60/652,318 2005-02-10
US70322505P 2005-07-27 2005-07-27
US60/703,225 2005-07-27
PCT/JP2006/302684 WO2006085684A2 (en) 2005-02-10 2006-02-09 Method of diagnosing bladder cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011256511A Division JP2012135301A (ja) 2005-02-10 2011-11-24 膀胱癌を診断する方法

Publications (3)

Publication Number Publication Date
JP2008532477A JP2008532477A (ja) 2008-08-21
JP2008532477A5 true JP2008532477A5 (enExample) 2009-03-19
JP5109131B2 JP5109131B2 (ja) 2012-12-26

Family

ID=36570700

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007535933A Expired - Fee Related JP5109131B2 (ja) 2005-02-10 2006-02-09 膀胱癌を診断する方法
JP2011256511A Ceased JP2012135301A (ja) 2005-02-10 2011-11-24 膀胱癌を診断する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011256511A Ceased JP2012135301A (ja) 2005-02-10 2011-11-24 膀胱癌を診断する方法

Country Status (5)

Country Link
US (3) US7998695B2 (enExample)
EP (5) EP1856278A2 (enExample)
JP (2) JP5109131B2 (enExample)
CN (1) CN101175862A (enExample)
WO (1) WO2006085684A2 (enExample)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1898563B (zh) 2003-09-24 2011-11-23 肿瘤疗法科学股份有限公司 诊断乳腺癌的方法
AU2005266948A1 (en) * 2004-07-23 2006-02-02 Pacific Edge Biotechnology Ltd. Urine markers for detection of bladder cancer
EP1851543A2 (en) 2005-02-24 2007-11-07 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
AU2006241235B2 (en) * 2005-04-22 2012-04-05 Eisai, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
TW200741009A (en) * 2005-07-01 2007-11-01 Oncotherapy Science Inc Methods of modulating SMYD3 for treatment of cancer
EP2004687A1 (en) * 2006-02-28 2008-12-24 Oncotherapy Science, Inc. Methods for damaging cells using effector functions of anti-cdh3 antibodies
JP5339291B2 (ja) * 2006-08-10 2013-11-13 オンコセラピー・サイエンス株式会社 乳癌に関連する遺伝子およびポリペプチド
WO2008023842A1 (en) * 2006-08-25 2008-02-28 Oncotherapy Science, Inc. Methods of screening for agents that inhibit binding between mphosph1 and prc1
CA2915560A1 (en) * 2006-10-17 2008-04-24 Tomoaki Fujioka Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
AU2013200566B2 (en) * 2006-10-17 2014-10-09 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
EP2468887A1 (en) * 2006-12-13 2012-06-27 Oncotherapy Science, Inc. TTK as tumor marker and therapeutic target for lung cancer
RS55447B1 (sr) 2007-04-05 2017-04-28 Morphotek Inc Metode za inhibiranje vezivanja endosijalina za ligande
JP5272134B2 (ja) 2007-06-14 2013-08-28 オンコセラピー・サイエンス株式会社 Ｓｍｙｄ３によるｖｅｇｆｒ１のメチル化調整因子を同定する方法
TW200908998A (en) * 2007-06-27 2009-03-01 Oncotherapy Science Inc Compositions and methods of treating cancer
EP2185732A1 (en) * 2007-07-30 2010-05-19 Oncotherapy Science, Inc. Cancer associated gene ly6k
ES2537323T3 (es) * 2007-08-20 2015-06-05 Oncotherapy Science, Inc. Péptido CDCA1 y agente farmacéutico que lo comprende
UA100127C2 (ru) 2007-08-20 2012-11-26 Онкотерапи Саенс, Инк. Пептид cdh3 и лекарственное средство, содержащее его
KR101543624B1 (ko) 2007-08-20 2015-08-11 온코세라피 사이언스 가부시키가이샤 Ｆｏｘｍ１ 펩티드 및 이를 포함하는 약학적 조성물
WO2009028580A1 (en) * 2007-08-24 2009-03-05 Oncotherapy Science, Inc. Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
WO2009113674A1 (ja) * 2008-03-14 2009-09-17 学校法人北里研究所 膀胱癌の診断
EP2297580B1 (en) 2008-06-09 2015-03-04 Oxford Biotherapeutics Ltd. Antibody against Ephrin Type-A receptor 7 for treatment of bladder cancer
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TWI526219B (zh) * 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
CA2729403A1 (en) 2008-06-30 2010-01-07 Oncotherapy Science, Inc. Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
TWI466680B (zh) 2008-08-01 2015-01-01 Oncotherapy Science Inc Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
TWI543767B (zh) 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
EP2362904B1 (en) * 2008-08-28 2016-11-16 Oncotherapy Science, Inc. Method of screening compounds for use in inhibiting depdc1 - znf224 binding
RU2011111411A (ru) * 2008-08-28 2012-10-10 Онкотерапи Сайенс, Инк. (Jp) Oip5 в качестве гена-мишени для терапии и диагностики рака
MX2011004176A (es) * 2008-10-22 2011-09-21 Oncotherapy Science Inc Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo.
US20110301056A1 (en) * 2008-12-12 2011-12-08 Oncotherapy Science, Inc. Nectin-4 for target genes of cancer therapy and diagnosis
GB0823445D0 (en) * 2008-12-23 2009-01-28 Univ Surrey Biomarker
EP3913367A1 (en) * 2008-12-30 2021-11-24 Children's Medical Center Corporation Method of predicting acute appendicitis
TWI469791B (zh) 2009-02-18 2015-01-21 Oncotherapy Science Inc Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
TW201102081A (en) 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
CN105132529A (zh) 2009-07-24 2015-12-09 吉第克生物技术有限公司 子宫内膜癌的标记物
US20120231472A1 (en) * 2009-11-07 2012-09-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2782620A1 (en) * 2009-12-01 2011-06-09 Compendia Bioscience, Inc. Classification of cancers
WO2011069014A1 (en) 2009-12-04 2011-06-09 Cedars-Sinai Medical Center Tox3 as a biomarker for breast cancer
GB0922085D0 (en) * 2009-12-17 2010-02-03 Cambridge Entpr Ltd Cancer diagnosis and treatment
CN102781964B (zh) 2009-12-28 2015-11-25 肿瘤疗法科学股份有限公司 抗cdh3抗体及其用途
TWI485245B (zh) 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
TWI538685B (zh) 2010-04-02 2016-06-21 腫瘤療法 科學股份有限公司 Ｅｃｔ２胜肽及含此胜肽之疫苗
EP2380991A1 (en) 2010-04-20 2011-10-26 Universitätsklinikum Hamburg-Eppendorf Method of determining the metastatic potential of a tumor
US20110262921A1 (en) * 2010-04-23 2011-10-27 Sabichi Anita L Test for the Detection of Bladder Cancer
WO2012009382A2 (en) * 2010-07-12 2012-01-19 The Regents Of The University Of Colorado Molecular indicators of bladder cancer prognosis and prediction of treatment response
US9120749B2 (en) 2010-07-30 2015-09-01 Oncotherapy Science, Inc. Quinoline derivatives and MELK inhibitors containing the same
EP2426216A1 (en) * 2010-09-01 2012-03-07 Institut Gustave Roussy (IGR) Prognostic and/or predictive biomarkers and biological applications thereof
EP2670866A4 (en) * 2011-04-05 2015-09-02 Translational Genomics Res Inst BIOMARKERS AND METHOD OF APPLICATION THEREFOR
HK1197276A1 (en) * 2011-06-22 2015-01-09 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of bladder cancer
DK2738255T3 (en) 2011-07-29 2017-03-06 Univ Tokushima ERAP1-Derived Peptide and its Use
US9458447B2 (en) 2011-08-12 2016-10-04 Oncotherapy Science, Inc. MPHOSPH1 peptides and vaccines including the same
RU2633503C2 (ru) 2011-10-28 2017-10-12 Онкотерапи Сайенс, Инк. Пептиды торк и содержащие их вакцины
US20150065366A1 (en) * 2011-11-11 2015-03-05 Metabolon, Inc. Biomarkers for Bladder Cancer and Methods Using the Same
EP3603678A3 (en) * 2011-12-14 2020-07-29 The Board of Regents of the University of Texas System Collateral gene inactivation biomarkers and targets for cancer therapy
AU2012366148B2 (en) 2012-01-19 2016-12-01 Oncotherapy Science, Inc. 1,5-naphthyridine derivatives and melk inhibitors containing the same
US20150030615A1 (en) * 2012-03-09 2015-01-29 Verastem, Inc. Biomarkers for cancer stem cells and related methods of use
EP2872531A4 (en) 2012-07-10 2016-04-06 Oncotherapy Science Inc LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
WO2014010231A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Kif20a epitope peptides for th1 cells and vaccines containing the same
EP2872532A4 (en) 2012-07-10 2016-04-13 Oncotherapy Science Inc CDCA1-EPITOPPEPTIDES FOR TH1 CELLS AND VACCINES THEREWITH
EA031631B1 (ru) 2012-09-27 2019-01-31 Чугаи Сеияку Кабушики Каиша Способ лечения или предупреждения злокачественного новообразования, способ отбора пациента, способ тестирования предрасположенности к злокачественному новообразованию у субъекта, гибридный полипептид и его применения
DE102012021222B4 (de) * 2012-10-27 2015-02-05 Forschungszentrum Jülich GmbH Verfahren zur Herstellung einer nanoporösen Schicht auf einem Substrat
CN103033625B (zh) * 2012-12-19 2014-12-24 中国科学院生物物理研究所 一种人膀胱癌细胞化学发光检测试剂盒及其制备方法
WO2014138396A1 (en) * 2013-03-06 2014-09-12 Cepheid Methods of detecting bladder cancer
EP2964782B1 (en) * 2013-03-08 2018-01-10 MDxHealth Research B.V. Molecular markers in bladder cancer
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
KR101573467B1 (ko) * 2013-04-10 2015-12-01 (주)지노믹트리 방광암 특이적 후성유전적 마커 유전자를 이용한 방광암의 검출방법
EP3066217A4 (en) * 2013-11-04 2017-10-11 The University Of British Columbia Cancer biomarkers and classifiers and uses thereof
MX2016017393A (es) 2014-07-01 2017-09-05 Pfizer Diacuerpos heterodimericos biespecificos y sus usos.
JP6700512B2 (ja) 2014-08-04 2020-05-27 オンコセラピー・サイエンス株式会社 Ｃｄｃａ１由来ペプチドおよびそれを含むワクチン
US10576097B2 (en) 2014-08-04 2020-03-03 Oncotherapy Science, Inc. URLC10-derived peptide and vaccine containing same
WO2016115089A1 (en) * 2015-01-12 2016-07-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Blood biomarkers for respiratory infections
WO2016154493A1 (en) * 2015-03-24 2016-09-29 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for multi-scale, annotation-independent detection of functionally-diverse units of recurrent genomic alteration
GB201511191D0 (en) * 2015-06-25 2015-08-12 Immatics Biotechnologies Gmbh T-cell epitopes for the immunotherapy of myeloma
US10676508B2 (en) 2015-08-12 2020-06-09 Oncotherapy Science, Inc. DEPDC1-derived peptide and vaccine containing same
AU2016334778B2 (en) 2015-10-08 2020-12-17 Oncotherapy Science, Inc. MPHOSPH1-derived peptide, and vaccine including same
SG11201802881YA (en) 2015-10-08 2018-05-30 Oncotherapy Science Inc Foxm1-derived peptide, and vaccine including same
US10635909B2 (en) * 2015-12-30 2020-04-28 Texas Instruments Incorporated Vehicle control with efficient iterative triangulation
JP6923135B2 (ja) 2016-01-19 2021-08-18 国立大学法人徳島大学 がん治療用ペプチド及びそれを含む医薬組成物
CN105886629B (zh) * 2016-04-29 2019-09-27 北京泱深生物信息技术有限公司 分子标志物在诊治食管鳞癌中的应用
CN107400704A (zh) * 2016-05-20 2017-11-28 博尔诚（北京）科技有限公司 一种用于乳腺癌筛查的组合物及其应用
JP6769596B2 (ja) * 2016-05-30 2020-10-14 学校法人北里研究所 膀胱癌診断薬及び生体試料の判定方法
AU2017318907B2 (en) 2016-08-31 2023-07-06 Oncotherapy Science, Inc. Monoclonal antibody against MELK and utilization thereof
TWI762516B (zh) 2016-10-06 2022-05-01 日商腫瘤療法 科學股份有限公司 針對ｆｚｄ１０之單株抗體及其用途
NL2020004B1 (en) 2016-12-09 2018-07-02 Ary Flohil Jacob Treatment of diffuse intrinsic pontine glioma
CN111148752B (zh) 2017-07-19 2024-01-16 国立大学法人德岛大学 肽衍生物和包含其的药物组合物
CN110018309B (zh) * 2018-01-08 2023-07-04 成都市第三人民医院 通过蛋白标志物判断结直肠癌预后的试剂盒
KR102171774B1 (ko) * 2018-06-04 2020-10-29 울산대학교 산학협력단 인산화된 tfcp2l1을 포함하는 고형암 예후 예측용 바이오마커 조성물 및 이의 용도
WO2019236853A1 (en) * 2018-06-06 2019-12-12 Exosome Diagnostics, Inc. Methods for developing urine biomarkers and for detecting bladder cancer
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
CN111206093A (zh) * 2018-11-21 2020-05-29 立森印迹诊断技术（无锡）有限公司 一种用于检测浸润性膀胱癌的标志物及其应用
JP7525855B2 (ja) 2018-11-30 2024-07-31 国立大学法人徳島大学 Ｂｉｇ３－ｐｈｂ２相互作用阻害ｐｈｂ２由来ペプチドを含む乳がん治療薬
CN110320369B (zh) * 2019-07-31 2022-05-17 天津医科大学第二医院 一种诊断膀胱癌试剂盒
CN112442499B (zh) * 2019-08-30 2026-03-10 恩康药业科技（广州）有限公司 一种抑制MCM7的siRNA、组合物及其应用
US20210379148A1 (en) * 2020-05-12 2021-12-09 University Of Maryland, Baltimore Regulating muscle physiology and energy metabolism using crym
WO2022038158A1 (en) * 2020-08-17 2022-02-24 Bicycletx Limited Bicycle conjugates specific for nectin-4 and uses thereof
CN115501340B (zh) * 2021-06-07 2024-04-12 中山大学附属第三医院（中山大学肝脏病医院） CircPIAS1作为靶点在制备肝癌诊断试剂或治疗药物中的用途
CN113322523B (zh) * 2021-06-17 2024-03-19 翌圣生物科技(上海)股份有限公司 Rna快速建库方法及其应用
CN114854860A (zh) * 2022-05-05 2022-08-05 北京化工大学 一种膀胱癌干细胞生物标志物组及其应用
CN116121373A (zh) * 2022-09-14 2023-05-16 中山大学孙逸仙纪念医院 Etv4及其表达产物在制备诊断和治疗膀胱癌药物中的应用
WO2024192018A1 (en) * 2023-03-12 2024-09-19 Novelna Inc. Bladder cancer detection proteins and methods of use thereof
CN117607435A (zh) * 2023-10-27 2024-02-27 中山大学孙逸仙纪念医院 翻译调控因子dhcr24在膀胱癌转移、预后、治疗中的应用
CN119633123A (zh) * 2024-12-26 2025-03-18 中山大学附属第一医院 Mettl2在消化系统肿瘤放疗增敏中的应用
CN120064671B (zh) * 2025-04-29 2025-07-29 吉林大学 用于检测幼儿唾液prb1含量的组合物及应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239102A3 (en) 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Process for the formation of human-human hybridoma
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US7001999B1 (en) * 1998-04-15 2006-02-21 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
US20020103360A1 (en) 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
AU1492601A (en) * 1999-09-27 2001-04-30 Quark Biotech, Inc. Sequences characteristic of bladder cancer
CA2402563A1 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001053535A2 (en) * 2000-01-20 2001-07-26 Cedars-Sinai Medical Center Method of detecting neoplastic, hyperplastic, cytologically dysplastic and/or premalignant cellular growth or proliferation
EP1325120A4 (en) * 2000-10-12 2005-05-25 Nuvelo Inc NUCLEIC ACIDS AND POLYPEPTIDES
US20030157561A1 (en) 2001-11-19 2003-08-21 Kolkman Joost A. Combinatorial libraries of monomer domains
US20040076955A1 (en) * 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
US7494646B2 (en) * 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
AU2003222103A1 (en) * 2002-03-28 2003-10-13 Idec Pharmaceuticals Corporation Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
EP2311948A1 (en) 2003-02-28 2011-04-20 Onco Therapy Science, Inc. RNA-interference for ZNFN3A1-gene as a method for inhibiting cancer cell growth
EP2343384A3 (en) 2004-03-23 2012-01-04 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancer
CA2915560A1 (en) 2006-10-17 2008-04-24 Tomoaki Fujioka Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
JP5272134B2 (ja) * 2007-06-14 2013-08-28 オンコセラピー・サイエンス株式会社 Ｓｍｙｄ３によるｖｅｇｆｒ１のメチル化調整因子を同定する方法

Similar Documents

Publication Publication Date Title
JP2009502115A5 (enExample)
JP2012135301A5 (enExample)
CN106103715B (zh) 沙门氏菌的非编码性rna及其鉴定和应用
JPWO2019159884A5 (enExample)
IL285107B1 (en) Diagnostic, prognostic and therapeutic uses of long non-coding RNA molecules for heart diseases and rehabilitation medicine
CA2488404A1 (en) Genes and polypeptides relating to human colon cancers
JP2006518186A5 (enExample)
JP2005537007A5 (enExample)
US20180127803A1 (en) Ultra sensitive probes for detection of nucleic acid
JP2012501164A5 (enExample)
CN106701986B (zh) 分子标志物在胃癌诊治中的应用
CN108753969B (zh) 长链非编码rna在肝细胞癌诊疗中的应用
JPWO2019208671A5 (enExample)
JP2005511023A5 (enExample)
CN113584027B (zh) 一种激活p21基因表达的方法
JP2009505633A5 (enExample)
JP2014523736A5 (enExample)
WO2020175898A1 (ko) Tut4/7 발현 조절인자를 포함하는 암 예방 또는 치료용 약학적 조성물
CN108192977A (zh) 一种与胃癌发生发展相关的分子标志物
CN108707672B (zh) Duxap8在肝细胞癌诊断和治疗中的应用
JP2006501465A5 (enExample)
JP2009523004A5 (enExample)
JP2010501162A5 (enExample)
WO2014043159A1 (en) Sera based mirnas as non-invasive biomarkers in melanoma
JP2009502114A5 (enExample)